ImmunityBio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-854.6	-351.47	-413.65	-583.85	-417.32	-349.85
Depreciation & Amortization	16.08	15.53	17.55	18.51	18.26	14.24
Stock-Based Compensation	35.44	36.81	34.43	49.16	40.18	57.18
Other Adjustments	527.42	48.53	-10.16	145.59	29.37	23.12
Change in Receivables	-26.24	-40.21	-2.36	-	-	-
Changes in Inventories	-11.14	-6.33	-8.27	-	-	-
Changes in Accounts Payable	-2.73	-0.19	-3.17	-6.48	8	-3.72
Changes in Accrued Expenses	19.25	3.18	-1.51	6.69	4.1	5.18
Changes in Other Operating Activities	-11.94	-10.79	-4.12	3.62	-20.1	-20.58
Operating Cash Flow	-294.39	-304.94	-391.24	-366.76	-337.51	-274.42
Capital Expenditures	-4.5	-3.85	-6.89	-30.58	-78.16	-33.56
Sale of Property, Plant & Equipment	-	-	-	-	-	20.5
Purchases of Intangible Assets	-0.01	-0.41	-	-	-21.23	-
Purchases of Investments	-390.37	-241.37	-140.22	-10.36	-35.31	-141.75
Proceeds from Sale of Investments	209.7	95.82	136.61	10.47	162	69.93
Payments for Business Acquisitions	-	-	-1	-	-	-
Other Investing Activities	-	-	-0.75	-	-	-
Investing Cash Flow	-185.58	-149.8	-12.25	-30.47	27.3	-84.89
Short-Term Debt Issued	0.06	2.88	-	-	-	-
Net Short-Term Debt Issued (Repaid)	0.06	2.88	-	-	-	-
Long-Term Debt Issued	75	-	96.96	451.46	174.13	338.5
Net Long-Term Debt Issued (Repaid)	75	-	96.96	451.46	174.13	338.5
Issuance of Common Stock	557.3	400.78	190.2	110.4	60.5	169.99
Repurchase of Common Stock	-8.06	-2.27	-5.47	-3.44	-0.62	-4.06
Net Common Stock Issued (Repurchased)	549.25	398.52	184.74	106.95	59.89	165.93
Other Financing Activities	-0.91	-1.16	-0.06	-0.08	-0.4	1.02
Financing Cash Flow	625.15	400.24	281.63	558.34	233.61	505.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.15	0.02	-0.02	-0.29	0.28	0.05
Net Cash Flow	145.33	-54.48	-121.88	160.82	-76.32	146.19
Free Cash Flow	-298.89	-308.78	-398.12	-397.34	-415.67	-307.98
FCF Margin	-212.01%	-272.56%	-2700.06%	-63881.20%	-173196.00%	-32974.50%
Free Cash Flow Per Share	-0.32	-0.34	-0.57	-0.78	-1.04	-0.79
Levered Free Cash Flow	-774.45	-350.95	-323	-139.98	-310.35	-46.73
Unlevered Free Cash Flow	-256.4	-258.37	-350.58	-370.47	-419.23	-368.73

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q